Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients
- PMID: 32114329
- PMCID: PMC7360056
- DOI: 10.1016/j.drugalcdep.2020.107939
Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients
Abstract
Background: Timeline Follow-back (TLFB) interviews using self-report are often used to assess substance use. Oral fluid testing (OFT) offers an objective measure of substance use. There are limited data on the agreement between TLFB and OFT.
Methods: In this secondary analysis from a multisite study in five primary care sites, self-reported TLFB and OFT data collected under confidential conditions were compared to assess concordance (N=1799). OFT samples were analyzed for marijuana, heroin, cocaine, and non-medical use of prescription opioids. Demographic differences in discordance relative to TLFB and OFT concordant results for marijuana, the only substance with an adequate sample size in this analysis, were examined using multinomial logistic regression.
Results: Overall concordance rates between TLFB and OFT were 94.9 % or higher for each substance, driven by large subgroups with no use. Among participants with discordant use, marijuana was the only substance with lower detection on OFT than self-report (27.6 % OFT-positive only vs 32.2 % TLFB-positive only), whereas cocaine (65.6 % vs 8.6 %), prescription opioids (90.4 % vs 6.0 %), and heroin (40.7 % vs 26.0 %) all had higher detection via OFT than TLFB. Participants who reported marijuana use but had a negative OFT were more likely to be younger, Hispanic, and White compared to those with TLFB and OFT concordant positive results.
Conclusions: TLFB and OFT show disparate detection of different substances. Researchers should consider the implications of using either self-report or oral fluid testing in isolation, depending on the substance and collection setting. Triangulating multiple sources of information may improve detection of drug use.
Keywords: Concordance; Discordance; Illicit drug use; Oral fluid testing; Primary care; Self-Report; Timeline follow-back.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflict of interest.
Similar articles
-
Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.Addiction. 2012 Jun;107(6):1123-31. doi: 10.1111/j.1360-0443.2011.03757.x. Epub 2012 Feb 13. Addiction. 2012. PMID: 22151583 Clinical Trial.
-
What happens to agreement over time? A longitudinal study of self-reported substance use compared to saliva toxicological testing among subsidized housing residents.J Subst Abuse Treat. 2019 Jun;101:12-17. doi: 10.1016/j.jsat.2019.03.002. Epub 2019 Mar 15. J Subst Abuse Treat. 2019. PMID: 31174709 Free PMC article.
-
Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users.Drug Alcohol Depend. 2016 Apr 1;161:29-35. doi: 10.1016/j.drugalcdep.2016.01.007. Epub 2016 Jan 21. Drug Alcohol Depend. 2016. PMID: 26880593 Free PMC article.
-
Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.Drug Alcohol Depend. 2014 Aug 1;141:44-50. doi: 10.1016/j.drugalcdep.2014.05.001. Epub 2014 May 17. Drug Alcohol Depend. 2014. PMID: 24932945 Free PMC article. Clinical Trial.
-
Hair analysis and its concordance with self-report for drug users presenting in emergency department.Drug Alcohol Depend. 2016 Oct 1;167:149-55. doi: 10.1016/j.drugalcdep.2016.08.007. Epub 2016 Aug 7. Drug Alcohol Depend. 2016. PMID: 27522871 Free PMC article. Clinical Trial.
Cited by
-
What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.Ann Epidemiol. 2022 Apr;68:45-53. doi: 10.1016/j.annepidem.2021.12.013. Epub 2022 Jan 3. Ann Epidemiol. 2022. PMID: 34990827 Free PMC article.
-
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.J Addict Med. 2023 Jul-Aug 01;17(4):471-473. doi: 10.1097/ADM.0000000000001139. Epub 2023 Feb 4. J Addict Med. 2023. PMID: 37579113 Free PMC article.
-
Test-Retest Reliability of a Timeline Follow-back Method to Assess Opioid Use and Treatment.J Addict Med. 2025 Feb 5:10.1097/ADM.0000000000001451. doi: 10.1097/ADM.0000000000001451. Online ahead of print. J Addict Med. 2025. PMID: 39908533
-
Cannabis use, comorbidities, and prescription medication use among older adults in a large healthcare system in Los Angeles, CA 2019-2020.J Am Geriatr Soc. 2022 Jun;70(6):1673-1684. doi: 10.1111/jgs.17719. Epub 2022 Mar 2. J Am Geriatr Soc. 2022. PMID: 35234291 Free PMC article.
-
A clinical science guide for reviewing the cross-cultural rigor of assessments in an alcohol training clinic.Psychol Serv. 2024 May;21(2):305-316. doi: 10.1037/ser0000738. Epub 2023 Jan 23. Psychol Serv. 2024. PMID: 36689373 Free PMC article. Review.
References
-
- Bell J 1998. Self report among injecting drug users. Drug and Alcohol Dependence, 51(3), 267–268. - PubMed
-
- Center for Substance Abuse Treatment. 1997. A guide to substance abuse services for primary care clinicians. - PubMed
-
- Cone EJ 1993. Saliva testing for drugs of abuse. Annals of the New York Academy of Sciences, 694(1), 91–127. - PubMed